Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
about
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of ImmunotherapyImmune reconstitution in chronic lymphocytic leukemiaRole of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a reviewAdoptive immunotherapy of metastatic breast cancer: present and future.Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over?Advances and Prospects in Cancer Immunotherapy
P2860
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
@en
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
@nl
type
label
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
@en
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
@nl
prefLabel
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
@en
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
@nl
P2093
P2860
P356
P1476
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
@en
P2093
Andreas A Hombach
Hinrich Abken
Patrick Schmidt
P2860
P304
P356
10.1155/2012/595060
P577
2011-08-08T00:00:00Z